RxDoctor Payments Data

Sarah Flanagan, OD

Optometrist · Atlanta, GANPI 1164084687

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $18,221 of the $21,252 with a category attached, or 85.7%. 19 manufacturers reported payments, led by Coopervision Inc. at 28.0% of the total. Reporting peaked in 2024 at $6,780 and has fallen 67.6% since, to $2,194 in 2025. Among optometrist clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,252in general payments, 2019–2025

Across 317 payments — averaging $67.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopervision Inc.$6K
  • Visioneering Technologies, Inc.$4K
  • Bausch & Lomb Americas Inc.$3K
  • Sun Pharmaceutical Industries Inc.$2K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$1K
  • Novartis$634
  • plus $4K from 13 others

What the payments were for

  • Consulting fees$2,0009%
  • Travel & lodging$7283%
  • Food & beverage$18,22186%
  • Entertainment$3031%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,252 in reported general payments places this provider in the 95th percentile of 1,285 optometrist providers in Georgia.

See all optometrist providers in Georgia

Medicare billing

Part B allowed, 2024
$41,041
Medicare patients
212
Services billed
3,459

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost40$738
Prednisolone Acetate25$693
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat11$191

Paid to pharmacies, not to this prescriber.

Other optometrist in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →